Phase I trials are clinical trials, i.e., human trials. The website and the MD&A show that a Phase 3 COVID-19 study is planned. Wideout has the trials mixed up but RVX might apply for an EUA as he notes -- perhaps after the Phase 2 trial? I don't know.
EUA is mentioned in the Eversana press release: "....a partnership to support planned commercialization of apabetalone....as Emergency Use Authorization and/or a New Drug Application or equivalent is issued or approved...."
The study description at clinicaltrials.gov shows the study as....
Phase 2
Phase 3
I'm not sure why it shows "Phase 3". Is that included to give them the option of morphing it into a Phase 3 trial if the Phase 2 is successful? I don't know.
